
Century Therapeutics, Inc.
IPSCHealthcare|Biotechnology|US
$1.68
+0.17 (+11.26%)
DCF Value
$2.59
Tangible Book / Share
$0.96
Cash / Share
$0.58
Next Earnings Report
Nov 12, 2026
EPS est. -$0.12 · Revenue est. $1.6M
Financing Filings (last 12 months)
4
Shelf registrations / offering prospectuses — latest May 21, 2026 (424B7). Possible dilution.
Upcoming Data Readouts (3)
Aug 2028
Est. completion
P1Systemic Lupus Erythematosus
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
NCT06255028n=6
Feb 2029
Est. completion
P3Intracerebral Haemorrhage
Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage
NCT07243704n=5,676
Mar 2040
Est. completion
Hematological Malignancy
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
NCT05768269n=375
Recent Press Releases
Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
Oct 14, 2026 · GlobeNewsWire
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
Oct 2, 2026 · GlobeNewsWire
Century Therapeutics Appoints Joseph Truitt to Board of Directors
Sep 9, 2026 · GlobeNewsWire
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
Aug 12, 2026 · GlobeNewsWire
SEC Filings (67)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 2, 2026 | 8-K | Material event | DocumentIndex |
| Sep 9, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 8-K | Material event | DocumentIndex |
| Aug 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| Jun 8, 2026 | 8-K | Material event | DocumentIndex |
| May 21, 2026 | 424B7 | Offering prospectus | DocumentIndex |
| May 15, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| May 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| May 13, 2026 | 8-K | Material event | DocumentIndex |
| May 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 27, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 16, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 16, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 26, 2026 | 8-K | Material event | DocumentIndex |
| Mar 26, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 12, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Mar 12, 2026 | 8-K | Material event | DocumentIndex |
| Mar 12, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 17, 2026 | EFFECT | DocumentIndex | |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 5, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jan 23, 2026 | 8-K | Material event | DocumentIndex |
| Jan 16, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 16, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 16, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 15, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 12, 2026 | 8-K | Material event | DocumentIndex |
| Jan 9, 2026 | EFFECT | DocumentIndex | |
| Jan 8, 2026 | 8-K | Material event | DocumentIndex |
| Jan 5, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Jan 5, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Dec 29, 2025 | 8-K | Material event | DocumentIndex |
| Dec 12, 2025 | 8-K | Material event | DocumentIndex |
| Dec 9, 2025 | 8-K | Material event | DocumentIndex |
| Dec 2, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Dec 2, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |